Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8784458rdf:typepubmed:Citationlld:pubmed
pubmed-article:8784458lifeskim:mentionsumls-concept:C0011588lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0039593lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0205419lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C1524075lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0439799lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:8784458lifeskim:mentionsumls-concept:C0337112lld:lifeskim
pubmed-article:8784458pubmed:issue18lld:pubmed
pubmed-article:8784458pubmed:dateCreated1996-10-17lld:pubmed
pubmed-article:8784458pubmed:abstractTextDequalinium is a potent and selective blocker of the small conductance Ca(2+)-activated K+ (SKCa) channel in rat sympathetic neurones. Analogues of dequalinium possessing 3-6, 8, 10, and 12 methylene groups in the linking chain have been synthesized and tested for inhibition of the afterhyperpolarization in rat sympathetic neurones. The compounds having a 5-12-carbon chain showed very little variation in their activity as SKCa channel blockers. The analogues possessing four and three methylenes exhibited 3- and 8-fold lower potency, respectively, compared with dequalinium. These results are discussed in the context of possible modes of binding of the compounds to the SKCa channel.lld:pubmed
pubmed-article:8784458pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:languageenglld:pubmed
pubmed-article:8784458pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:citationSubsetIMlld:pubmed
pubmed-article:8784458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784458pubmed:statusMEDLINElld:pubmed
pubmed-article:8784458pubmed:monthAuglld:pubmed
pubmed-article:8784458pubmed:issn0022-2623lld:pubmed
pubmed-article:8784458pubmed:authorpubmed-author:GanellinC RCRlld:pubmed
pubmed-article:8784458pubmed:authorpubmed-author:DunnP MPMlld:pubmed
pubmed-article:8784458pubmed:authorpubmed-author:MalikSSlld:pubmed
pubmed-article:8784458pubmed:authorpubmed-author:GalanakisDDlld:pubmed
pubmed-article:8784458pubmed:issnTypePrintlld:pubmed
pubmed-article:8784458pubmed:day30lld:pubmed
pubmed-article:8784458pubmed:volume39lld:pubmed
pubmed-article:8784458pubmed:ownerNLMlld:pubmed
pubmed-article:8784458pubmed:authorsCompleteYlld:pubmed
pubmed-article:8784458pubmed:pagination3592-5lld:pubmed
pubmed-article:8784458pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:meshHeadingpubmed-meshheading:8784458-...lld:pubmed
pubmed-article:8784458pubmed:year1996lld:pubmed
pubmed-article:8784458pubmed:articleTitleSynthesis and pharmacological testing of dequalinium analogues as blockers of the apamin-sensitive Ca(2+)-activated K+ channel: variation of the length of the alkylene chain.lld:pubmed
pubmed-article:8784458pubmed:affiliationDepartment of Chemistry, University College London, U.K.lld:pubmed
pubmed-article:8784458pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8784458pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:8784458lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8784458lld:pubmed